Table 2. Multivariate logistic regression models to identify risk factors associated with aortic dilation.
Model 1* | Model 2** | ||||
---|---|---|---|---|---|
Clinical predictor of AD | Odds ratio (OR) | 95% CI range | Clinical predictor of AD | Odds ratio (OR) | 95% CI range |
BMI Z-score | 0.52 | 0.35 – 0.78 | BMI Z-score | 0.47 | 0.26 – 0.84 |
Presence of glomerular disease | 4.58 | 1.45 – 14.46 | Presence of glomerular disease | 12.34 | 1.9 – 79 |
Weight (kg) | 0.98 | 0.96 – 1.01 | Weight (kg) | 0.98 | 0.94 – 1.01 |
SBP index > 1 | 1.176 | 0.01 – 250 | SBP index >1 | 1.08 | 0.1 – 413 |
DBP index > 1 | 1.35 | 0.02 – 118 | DBP index >1 | 6.57 | 0.04 – 545 |
Left ventricular mass index 2.7 m2 | 0.99 | 0.96- 1.02 | |||
Presence of dyslipidemia | 0.51 | 0.09 – 3.01 | |||
Ca × P | 0.20 | 0.04 – 1.5 | |||
Hgb | 0.86 | 0.48 – 1.55 | |||
iPTH | 1.00 | 0.99 – 1.01 | |||
Albumin | 0.32 | 0.10 – 1.03 |
BMI = body mass index; BP = blood pressure; Ca × P = calcium × phosphorus product; DBP = diastolic blood pressure; Hgb = hemoglobin; iPTH = parathyroid hormone; SBP = systolic blood pressure. *Model 1 includes the covariates of p-vales ≤ 0.15 in univariate analysis (Table 1). The hemodialysis parameters of normalized interdialytic weigh gain and normalized ultrafiltration were not included in the model because these values are available for less than 50% of the cohort (37/97 patients). **Model 2 includes the variables in model 1 in addition to other clinical variables that are known to be associated with cardiovascular and morbidity risk in ESRD population.